Company / Operating Income
Bio-Techne Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$102.3M
FY2025
5-year range
$102.3M / $237.3M
FY2021-FY2025
Trend
-50.5%
vs FY2024
Sector context
#74 of 156
Health Care
What the data says
At $102M, Bio-Techne's operating income ranks #74 of 156 in the Health Care sector. Operating Income has fluctuated over the past 10 years, ranging from $102M in FY2025 to $237M in FY2023.
Based on SEC 10-K filings.
$102M in FY2025 with a 5-year CAGR of -8.3%.
Declined from $237M to $102M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -13.4%
- 5-Year CAGR
- -8.3%
- 10-Year CAGR
- -
Sector benchmark
#74 of 156 in Health CareTop 47% of 156This company $102.3M Sector average $733.1M
▼
-86.1% below sector average
Key checks
Key Insights
- 5-year CAGR of -8.3%, indicating a declining trend.
- In FY2025, operating income decreased 50.5% year-over-year.
- Ranks #74 out of 156 companies in the Health Care sector.
- Peak operating income was recorded in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $102.3M | -50.5% |
| FY2024 | $206.7M | -12.9% |
| FY2023 | $237.3M | +50.7% |
| FY2022 | $157.4M | +7.3% |
| FY2021 | $146.7M | -6.8% |
| FY2020 | $157.4M | +7.3% |
| FY2019 | $146.7M | +7.7% |
| FY2018 | $136.2M | +12.9% |
| FY2017 | $120.6M | -19.9% |
| FY2016 | $150.6M | +2.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026